136 related articles for article (PubMed ID: 23541833)
1. Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators.
Liu Z; MacRitchie N; Pyne S; Pyne NJ; Bittman R
Bioorg Med Chem; 2013 May; 21(9):2503-10. PubMed ID: 23541833
[TBL] [Abstract][Full Text] [Related]
2. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
[TBL] [Abstract][Full Text] [Related]
3. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
Tonelli F; Lim KG; Loveridge C; Long J; Pitson SM; Tigyi G; Bittman R; Pyne S; Pyne NJ
Cell Signal; 2010 Oct; 22(10):1536-42. PubMed ID: 20570726
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
[TBL] [Abstract][Full Text] [Related]
5. Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.
Lim KG; Tonelli F; Berdyshev E; Gorshkova I; Leclercq T; Pitson SM; Bittman R; Pyne S; Pyne NJ
Int J Biochem Cell Biol; 2012 Sep; 44(9):1457-64. PubMed ID: 22634604
[TBL] [Abstract][Full Text] [Related]
6. Chiral vinylphosphonate and phosphonate analogues of the immunosuppressive agent FTY720.
Lu X; Sun C; Valentine WJ; Shuyu E; Liu J; Tigyi G; Bittman R
J Org Chem; 2009 Apr; 74(8):3192-5. PubMed ID: 19296586
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2.
Hara-Yokoyama M; Terasawa K; Ichinose S; Watanabe A; Podyma-Inoue KA; Akiyoshi K; Igarashi Y; Yanagishita M
Bioorg Med Chem Lett; 2013 Apr; 23(7):2220-4. PubMed ID: 23434415
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase 1 (SK1) allosteric inhibitors that target the dimerization site.
Bayraktar O; Ozkirimli E; Ulgen K
Comput Biol Chem; 2017 Aug; 69():64-76. PubMed ID: 28587987
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of dansyl labeled sphingosine kinase 1 inhibitor.
Park EY; Lee T; Oh YS; Lee JY; Shrestha J; Hong SW; Jin YJ; Jo G; Kim S; Hwang GT; Han DS; Baek DJ
Chem Phys Lipids; 2018 Sep; 215():29-33. PubMed ID: 30044952
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of targeting SK1 in human cancers.
Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
[TBL] [Abstract][Full Text] [Related]
11. Novel meriolin derivatives as rapid apoptosis inducers.
Drießen D; Stuhldreier F; Frank A; Stark H; Wesselborg S; Stork B; Müller TJJ
Bioorg Med Chem; 2019 Aug; 27(15):3463-3468. PubMed ID: 31248707
[TBL] [Abstract][Full Text] [Related]
12. (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity.
Valentine WJ; Kiss GN; Liu J; E S; Gotoh M; Murakami-Murofushi K; Pham TC; Baker DL; Parrill AL; Lu X; Sun C; Bittman R; Pyne NJ; Tigyi G
Cell Signal; 2010 Oct; 22(10):1543-53. PubMed ID: 20566326
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
[TBL] [Abstract][Full Text] [Related]
14. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart.
Vessey DA; Kelley M; Zhang J; Li L; Tao R; Karliner JS
J Biochem Mol Toxicol; 2007; 21(5):273-9. PubMed ID: 17912702
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of selective inhibitors of sphingosine kinase 1.
Baek DJ; MacRitchie N; Pyne NJ; Pyne S; Bittman R
Chem Commun (Camb); 2013 Mar; 49(21):2136-8. PubMed ID: 23388656
[TBL] [Abstract][Full Text] [Related]
16. An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.
Vettorazzi M; Angelina E; Lima S; Gonec T; Otevrel J; Marvanova P; Padrtova T; Mokry P; Bobal P; Acosta LM; Palma A; Cobo J; Bobalova J; Csollei J; Malik I; Alvarez S; Spiegel S; Jampilek J; Enriz RD
Eur J Med Chem; 2017 Oct; 139():461-481. PubMed ID: 28822281
[TBL] [Abstract][Full Text] [Related]
17. The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells.
Tonelli F; Alossaimi M; Natarajan V; Gorshkova I; Berdyshev E; Bittman R; Watson DG; Pyne S; Pyne NJ
Biomolecules; 2013 Jun; 3(2):316-33. PubMed ID: 24970170
[TBL] [Abstract][Full Text] [Related]
18. Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
Yoshimitsu Y; Oishi S; Miyagaki J; Inuki S; Ohno H; Fujii N
Bioorg Med Chem; 2011 Sep; 19(18):5402-8. PubMed ID: 21868240
[TBL] [Abstract][Full Text] [Related]
19. In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1).
Bayraktar O; Ozkirimli E; Ulgen KO
Curr Protein Pept Sci; 2018; 19(5):430-444. PubMed ID: 27829348
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation.
El-Shewy HM; Abdel-Samie SA; Al Qalam AM; Lee MH; Kitatani K; Anelli V; Jaffa AA; Obeid LM; Luttrell LM
Mol Endocrinol; 2011 Dec; 25(12):2144-56. PubMed ID: 22016563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
